Drug Utilization Research

(P-008) Sex Differences in Lipid Profile Across the Life Span in Patients with Type 2 Diabetes: A Cross-sectional Study

(P-010) Slovenia versus the Netherlands: A Comparison of Opioid Prescription Strategies

(P-011) Drug Utilization Research in Africa: overview of Demographic and Socioeconomic Profile, Health Systems and Epidemiology

(P-013) Opioid Consumption from 2013 to 2016 in South Africa: Morphine, Pethidine, Oxycodone and Tramadol

(P-014) Dispensing Patterns of Antithrombotic Agents in South Africa with Specific Focus on the Direct Oral Anticoagulants (DOACs): A Database Analysis

(P-015) Impact of the Introduction of Generic Equivalents on Memantine Consumption in South Africa Using the ATC/DDD Methodology

(P-041) Scope of Insulin Human Utilization in Females of Childbearing Age in the US

(P-049) Prevalence and Factors Associated with Oral Anticoagulant Use in the General Nursing Home Population

(P-058) Process Evaluation of Implementing a Pharmacist-led Intervention to Improve Adherence to Antihypertensive Drugs Among Patients with Type 2 Diabetes in Indonesian Community Health Centers

(P-066) Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data

(P-074) Sex Difference, Label Indications and Trend in Atypical Antipsychotics Use in Early-onset Schizophrenia: A Nationwide Cross-sectional Study

(P-075) Visualization Methods to Examine Treatment Patterns in Pharmacoepidemiology: An Example Using Osteoporosis Medications

(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)

(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases

(P-089) Clinical and Cost-saving Effects of the Drug Utilization Review Modernization Pilot Project in Inpatient and Outpatient Settings in Korea

(P-090) Classification of Gabapentinoids as Controlled Drugs Reduced Gabapentinoid Prescriptions in Primary Care in England

(P-097) Characterizing Patients Using Abuse-deterrent Formulations of Extended-release Opioid Analgesics

(P-109) Misuse of Antimicrobials in the Rural Population of a District in South India

(P-114) Comedication of Opioids with Benzodiazepines, Gabapentinoids Among Caregivers of Children with Special Healthcare Needs

(P-117) A Rapid Review on the Adherence to Evidence-based Medical Therapy in Peripheral Artery Disease Patients

(P-122) An Evidence-based Evaluation of Clinical Medicine Use Indicators in Children

(P-139) Consumption Patterns of Chronic Medication During the COVID-19 Pandemic in Portugal

(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019

(P-142) Non-persistence with Statins in Diabetic and Non-diabetic Patients with Transient Ischemic Attack

(P-145) Real World Utilization of 91-day Extended Levonorgestrel-containing Combined Oral Contraceptives in Europe: A Multinational Database Study

(P-152) The Use of Medication Among People with Stage 2 Hypertension: Findings from an Indonesian Cross-sectional Study

(P-153) Patterns of Meropenem Utilization and Resistance at a Kenyan Public Referral Hospital

(P-158) The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study

(P-159) Impacts of Pharmacists’ Intervention on Drug-related Problems in Treatment for Pediatric Outpatients in Vietnam

(P-160) Impact Analysis of the COVID-19 Epidemic on the Patterns of Access to Medicines of Patients with Common Chronic Diseases in Beijing

(P-162) Key Opportunities and Future Direction for Drug Utilization Research in Africa

(P-165) Trends of Anti-epileptic Drugs Use During Pregnancy in Manitoba, Canada: A 20-year Utilization Study

(P-170) How Government Health Insurance Coverage of Novel Anti-cancer Medicines Benefited Cancer Patients in China: A Retrospective Analysis of the Insurance Claim Data

(P-178) Patterns of Antihypertensive Drugs Use After Primary Stroke in the General Population

(P-184) Prevalence and Predictors of Potentially Inappropriate Psychotropic (PIP) Medications in Older Adults with Psychiatric Illness

(P-185) Prevalence of Potentially Inappropriate Medication and Its Correlates in Elderly Hospitalized Patients: A Cross‑sectional Study Based on Beers Criteria

(P-186) Prevalence of Potentially Inappropriate Medication in Elderly Inpatients with Chronic Kidney Disease (CKD)

(P-187) Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-sectional Study

(P-198) Pharmacist-led Intervention to Support Deprescribing of Cardiometabolic Medication Among People with Type 2 Diabetes: A Pilot Study

(P-231) Association Between Non-adherence to Endocrine Therapy and the Risk of Recurrence Among Breast Cancer Survivors: A Systematic Literature Review

(P-232) Opioid Use Patterns Among Non-metastatic Cancer Survivors: A Systematic Literature Review

(P-237) Antimicrobial Use in Patients Diagnosed with Chronic Kidney Disease Admitted in the Internal Medical Wards at Dr George Mukhari Academic Hospital

(P-243) Healthcare Resource Use in a US Claims Database During the Early Period of the COVID-19 Pandemic

(P-256) Real-world Treatment Patterns of Newly Diagnosed Patients with Asthma And/or COPD

(P-264) Evaluation of Esketamine Adverse Event from the FAERS Database and Published Case Reports

(P-280) Temporal Trends in Medication Utilization Among Hospitalized COVID-19 Patients

(P-284) High Adherence and Sustained Virologic Response Among Vulnerable People Initiating an Hcv Treatment at a Community-based Nurse-led Clinic: A Cohort Study

(P-296) Drug Utilization Evaluation of Duloxetine

(P-298) Carboplatin Appropriateness and Rationality Assessment

(P-301) Drug Use Evaluation of Cephalosporins in Patients with Culture Report of Enterococcus Faecalis or Enterococcus Faecium

(P-302) Drug Utilization Evaluation for the Treatment of Vulvovaginal Candidiasis

(P-304) Drug Use Evaluation of Fentanyl Buccal Soluble Film

(P-305) Drug Utilization Evaluation of Pregabalin

(P-306) Drug Use Evaluation of Vytorin

(P-311) Characterization of Polypharmacy in Middle-aged and Elderly Adults in the UK: An Analysis of 0.5 million People in UK Biobank

(P-314) Time Trends in Patient Characteristics of New Rivaroxaban (RVX) Users with Atrial Fibrillation (AF) Across Four Countries

(P-319) Prevalence of Adverse Drug Reactions in the Primary Care Setting: A Systematic Review and Meta-analysis

(P-320) Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting, 2006-2016

(P-324) Prescribing Trends of Antihypertensive Drug Classes in a Hong Kong Dementia Cohort

(P-327) POPPY II Cohort Profile– a Population-based Linked Cohort Examining the Course and Outcomes of Prescription Opioid Use in NSW, Australia, 2003-2018

(P-328) The Utilization Evaluation of Intravenous Pantoprazole for Stress Ulcer Prophylaxis in a Major Teaching Hospital

(P-329) Evaluation of Albumin Utilization in a Major Teaching Hospital in Iran Before and After Guideline Implementation

(P-335) Pilot Study Rectifies Real World Study Design to Support Regulatory Decision Making

(P-351) COVID-19 Treatment Approaches Among Hospitalized Patients in a National Healthcare System

(P-357) Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation

(P-369) Patterns of Prescription and Co-prescription of Opioids and Benzodiazepines in the Period 2010 to 2018: A Real-world, Population-based Study

(P-370) Antithrombotic Therapy Prescription Patterns in the Secondary Prevention of Stroke in Patients with Atrial Fibrillation: Findings from a Real-world, Population-based Study

(P-389) Utilisation and Safety of Glycopyrronium Bromide (GPB) Oral Solution for the Treatment of Sialorrhoea in Children <18 Years in the UK

(P-390) A Contemporary Characterization of Patients with Non-valvular Atrial Fibrillation Starting Oral Anticoagulants in Quebec, Canada

(P-397) Medicines Use by Professors at a Brazilian Public University During the covid-19 Pandemic: Findings and Implications

(P-398) Treatment Patterns and Appropriateness of Antipsychotic Prescriptions in Patients with Schizophrenia

(P-403) Impact of H. pylori Eradication Therapy After the Introduction of Endoscopic Screening for Gastric Cancer in Japan

(P-404) A Systematic Review of Global Oncology Treatment Practice and Modifications During COVID-19

(P-405) Characteristics of Patients Initiating Spiriva Respimat for Asthma in the UK

(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎

(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study

(P-412) Antimicrobial Resistance in Endodontic Infections in Latin America (MICROBE-DENT): Systematic Review

(P-413) Incentive Structure of Employer Health Insurance and Impact on Patient Drug Use and Cost of Accessing the Private Primary Healthcare System

(P-414) Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany

(P-415) Real-world Treatment Trajectories for Newly Diagnosed Type 2 Diabetes Mellitus in Patients with Metastatic Cancer

(P-418) Optimization of Prescription Patterns: A Response to Control High Pharmaceutical Expenditure

(P-450) Incidence in Pharmacoepidemiology – New on the Drug versus New on the Class of Drugs

(P-461) Prescription Opioid Use in Australian Women of Reproductive Age from 2013 to 2020

(P-463) Comparative Analysis on the Evolution of Antimicrobial Resistance Surveillance and Governance Between China and the United States

(P-465) Avoidable Public Expenditures with Selected Antineoplastic Drugs for Breast Cancer in Brazil

(P-472) Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy

(P-475) Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data

(P-488) Estimates of Paracetamol Poisoning in Brazil: Analysis of Official Records

(P-491) Real- world Utilization of Octreotide Immediate Releasing Use with Octreotide Long-acting Releasing

(P-493) Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States

(P-494) Patterns of Antimicrobial Prescribed to Patients Admitted to a Tertiary Care Hospital in South-west Nigeria: A Prescription Quality Audit

(P-495) Persistence to Treatment After Percutaneous Coronary Intervention for Acute Coronary Syndrome Patients as a Cost-saving Opportunities in Indonesia

(P-496) Association Between Persistence to Treatment After Percutaneous Coronary Intervention and Clinical Outcomes in Acute Coronary Syndrome Patients: A Multicenter Study in Indonesia

(P-500) Impact of Chronic Diseases on the Adherence to Guidelines for the Treatment of Urinary Tract Infection in Quebec, Canada

(P-513) Trends in Hydroxychloroquine Drug Utilization and Safety in 2020

(P-523) Temporal Trends of Pharmacologic Treatments for tuberculosis and Multidrug-resistant tuberculosis Following Treatment Guideline Dissemination in South Korea

(P-527) Evaluating the Impact of New Prescribing Restrictions for Publicy-subsidised Proton Pump Inhibitors in Australia: An Interrupted Time Series Analysis

(P-529) Treatment Trajectory of Antihypertensive Drugs in UK Primary Care Practices

(P-534) Impacts of Prescription Drug Monitoring Program on Patients with Cancer

(P-559) Trends and Patterns in Traditional Chinese Medicine Use Among Chinese Population in Late Adulthood: An Eight-year Repeated Panel Survey

(P-564) Melatonin Use Among Children, Adolescents, and Young Adults. a Danish Nationwide Drug Utilization Study

(P-574) Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)